Colgate-Palmolive (India) Limited reported a 9% year-on-year increase in net sales to Rs 1,583 crore for the quarter ended March 31, 2026, driven by broad-based performance across its portfolio. The company’s board approved the audited financial results for the fourth quarter and financial year ended March 31, 2026, alongside a second interim dividend of Rs 24 per share. The total dividend for FY26 amounts to Rs 48 per share, with the payout scheduled for June 17, 2026.

For the quarter ended March 31, 2026, net profit stood at Rs 353 crore, compared to Rs 355 crore in the corresponding period of the previous year. The company reported an exceptional item expense of Rs 1,658 lakh related to severance and organisational changes. Excluding one-offs and exceptional items, net profit grew by 9% year-on-year. Advertising expenses increased by 10% to Rs 1,990 crore, reflecting continued emphasis on premiumisation.

For the full year ended March 31, 2026, net sales were flat at Rs 5,984 crore. Net profit after tax declined to Rs 1,325 crore from Rs 1,437 crore in the previous year, impacted by inverted duty structure charges due to GST changes and higher interest on tax refunds in the base year. The statutory auditors, M/s. S R B C & CO LLP, issued an audit report with an unmodified opinion on the financial results.

Financial Performance

The following table outlines the financial results for the quarter and year ended March 31, 2026:

Board Decisions

The board approved the re-appointment of Mr. Jacob Sebastian Madukkakuzy as Whole-time Director & Chief Financial Officer for a term of five years commencing October 28, 2026, subject to shareholder approval. The 85th Annual General Meeting (AGM) is scheduled for July 29, 2026, via video conference. The register of members will remain closed from July 23, 2026, to July 29, 2026, for the AGM.

The company confirmed it does not fall under the category of Large Corporate as on March 31, 2026, as per SEBI circulars, having no outstanding long-term borrowings exceeding Rs 1,000 crore and no issued debt securities.

Colgate-Palmolive (India) continues to face a cautious outlook from global brokerage Citi, which has maintained its Sell rating on the stock with a target price of ₹2,050. The brokerage's stance reflects a nuanced assessment of the company's near-term growth dynamics, competitive landscape, and profitability profile.

Growth Trajectory and Pricing Dynamics

Citi acknowledges a more balanced growth trajectory for Colgate-Palmolive (India), supported by a favorable base effect and the return of pricing as a growth lever. However, the brokerage notes that competitive pressures in the oral care segment continue to constrain realizations, limiting the full benefit of pricing actions taken by the company.

Key Ratings and Target Summary

The following table outlines the key parameters of Citi's rating on Colgate-Palmolive (India):

Premiumization as the Core Growth Engine

Premiumization has been identified by Citi as the key growth driver for Colgate-Palmolive (India). The company's strategy of moving consumers toward higher-value products is seen as central to sustaining revenue momentum, even as volume growth faces headwinds from a competitive operating environment.

Margin Outlook Remains Mixed

Despite healthy gross margins, Citi points to continued margin trade-offs at the operating level. This suggests that while input cost dynamics may be supportive, increased spending on brand-building, distribution, or competitive responses is likely weighing on overall profitability metrics, according to the brokerage's assessment.

Analyst Stance

Citi's maintained Sell rating underscores a cautious view on the stock's near-term risk-reward profile. The combination of competition-driven realization pressures, reliance on premiumization for growth, and margin trade-offs forms the basis of the brokerage's below-consensus positioning on Colgate-Palmolive (India).